Psychedelic Stocks Archives - Page 33 of 61

WednesdayMar 08, 2023 2:03 pm

Risks of Buying Psilocybin Mushrooms from Online Suppliers

An analysis of data collected by the National Survey on Drug Use and Health from 2015–2018 found that an estimated 9.68% of Americans reported lifetime psilocybin use despite the psychedelic’s controlled status at the federal level. However, now that recent research has revealed that psychedelics such as psilocybin, ketamine and mescaline have mental health benefits, their popularity has skyrocketed. Investors are pouring millions of dollars into research to develop psychedelic-assisted therapies, while lawmakers across the country are considering legislation to allow psychedelic use for medical purposes. In the meantime, a market for psilocybin has emerged online that grants Americans across…

TuesdayMar 07, 2023 1:46 pm

VA Starts Considering Psychedelics as PTSD Treatments

After decades of federal prohibition prevented the research and medical use of psychedelic drugs, the U.S. Department of Veteran Affairs is now considering opening the door to psychedelic treatments for veterans. Research in the 1960s first revealed that psychedelics had therapeutic properties, but prohibition made it impossible for researchers to study hallucinogenic drugs. A recent surge in psychedelic research has shown that psychedelics such as ketamine, ayahuasca and psilocybin, can treat mental disorders, including treatment-resistant depression, post-traumatic stress disorder and anxiety. This makes these substances perfect for military veterans who have an elevated risk of developing conditions such as PTSD…

MondayMar 06, 2023 2:01 pm

Genetic Testing May Predict Individuals’ Reaction to Psychedelics

Recent advancements in psychedelic research have revealed that hallucinogenic drugs, such as psilocybin and LSD, may have potent therapeutic properties. Studies into the effects of psychedelics on mental health have found that they can treat the symptoms of various mental disorders with minimal side effects. When combined with psychotherapy, psychedelics have been found to deliver profound and long-term benefits to users at minimal doses. Lawmakers in several states are currently working on legislation to expand psychedelic research and allow the general public to access psychedelic-assisted psychotherapy. However, before psychedelic therapies can hit the market in masses, researchers will have to…

FridayMar 03, 2023 11:51 am

Research Finds Mystical Psychedelic Experiences May Boost Mental Health

Psychedelics are poised to revolutionize the psychiatric industry over the next couple of decades. In the midst of a global mental health crisis that has affected more than a billion people around the world, researchers have been working to develop psychedelic-assisted therapies to treat a myriad of mental health disorders. Research has revealed that psychedelics can treat the symptoms of conditions such as post-traumatic stress disorder, treatment-resistant depression, anxiety and even eating disorders. Furthermore, prior studies have shown that psychedelics can deliver long-term benefits at relatively small doses and with hardly any negative side effects. A recent study has now…

ThursdayMar 02, 2023 12:56 pm

Researchers Look Into Use of Psilocybin as Cluster Headaches Treatment

Researchers are looking to the nascent psychedelics market to find an alternative treatment for cluster headaches. A growing body of literature has already revealed that psychedelics can be effective at treating a myriad of mental health disorders when paired with psychotherapy. In fact, the majority of the research involving psychedelics, including psilocybin, MDMA and ketamine, has involved their potent mental health benefits. Yale University researchers have now published the results of the first-ever randomized double-blind, placebo-controlled study on the effects of psilocybin, the main psychoactive agent in magic mushrooms, on cluster headaches. These headaches are a rare neurological condition that…

WednesdayMar 01, 2023 1:00 pm

Research Finds That Psychedelics May Help Smokers Reinvent Themselves

Psychedelic therapies have become very popular these last few years after different studies found that these drugs could be useful in the treatment of a range of mental health conditions, including substance use disorder. A new study, carried out by scientists at the University of Cincinnati, has determined that psychedelics may be useful in helping people stop smoking. A previous study, carried out by scientists at Johns Hopkins University, also determined that participants who wanted to stop smoking and used psilocybin combined with cognitive behavioral therapy were more likely to succeed than individuals who tried other techniques to quit smoking.…

TuesdayFeb 28, 2023 1:17 pm

Psychedelic Medicine Firm Pioneers Ayahuasca Pill

Ayahuasca is one of the several psychedelics that have exhibited significant potential as treatment for mental health disorders. Research has revealed that psychedelics such as ayahuasca are capable of alleviating the symptoms of conditions, including treatment-resistant depression and post-traumatic stress disorder, with minimal side effects. However, most of this research is in its infancy, and patients who are interested in psychedelic treatments either have to take part in clinical trials or travel long distances to access institutions that offer psychedelic-assisted therapy. Ayahuasca, for instance, has a rich history in Central and South America and has been traditionally used by some…

MondayFeb 27, 2023 2:08 pm

Oregon Nonprofit Donates $50,000 in Scholarships for Training Psychedelics Guides

The Healing Advocacy Fund is a nonprofit organization that works to implement high-quality, safe and equitable psychedelic therapy. Research has found that psychedelics such as psilocybin have the potential to treat mental health conditions, including depression, post-traumatic stress disorder and end-of-life anxiety, among other conditions. The organization supports the implementation of the psilocybin therapy program in the state of Oregon through advocacy and education. Earlier this year, Oregon became the first state in the United States to launch a legal psilocybin medicinal use program. The next day, Oregon Psilocybin Services started accepting applications for five types of licenses: manufacturer, facilitator,…

FridayFeb 24, 2023 11:39 am

Combining VR, Psychedelics May Be Effective Therapy

Psychedelic-assisted therapy has emerged as a possible alternative to pharmaceutical psychiatric medications in recent years. A growing body of research has revealed that hallucinogenic drugs such as ketamine, MDMA and psilocybin have therapeutic potential against mental health disorders, including depression and PTSD. When paired with psychotherapy, psychedelics induce profound and long-term benefits relatively quickly and with minimal doses. As the psychedelics for mental health segment is still in its infancy, researchers are still working to develop psychedelic-assisted therapies that could be deployed to the mass market. Some researchers have begun experimenting with virtual reality (VR) to figure out how physicians…

ThursdayFeb 23, 2023 2:51 pm

European Union Urged to Play Active Role in Psychedelic Research

In just a few short years, psychedelics have presented themselves as a potential alternative to pharmaceutical mental health therapies. Research into hallucinogenic drugs has revealed that they are capable of alleviating the symptoms of mental disorders, such as treatment-resistant depression, anxiety and PTSD, when paired with psychotherapy. But while countries such as the United States and Australia have taken great strides towards increasing psychedelic research and incorporating psychedelics into existing mental health treatment frameworks, the European Union is still trailing behind. A cross-party group of legislators is now calling on the EU to step up its efforts and act fast…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks